These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25103564)

  • 1. Risks in the balance: the statins row.
    Hawkes N
    BMJ; 2014 Aug; 349():g5007. PubMed ID: 25103564
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins and The BMJ.
    Godlee F
    BMJ; 2014 Aug; 349():g5038. PubMed ID: 25103228
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
    Barter PJ; Rye KA
    Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
    [No Abstract]   [Full Text] [Related]  

  • 4. What you should know about: statins.
    Harv Health Lett; 2012 Oct; 37(12):7. PubMed ID: 23243693
    [No Abstract]   [Full Text] [Related]  

  • 5. The debate on statins must stay in the public domain.
    Burne J
    BMJ; 2014 Sep; 349():g5383. PubMed ID: 25185435
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins in Persons at Low Risk of Cardiovascular Disease.
    Abramson J
    Am Fam Physician; 2017 Nov; 96(9):Online. PubMed ID: 29094882
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on statins: 2003.
    Vaughan CJ; Gotto AM
    Circulation; 2004 Aug; 110(7):886-92. PubMed ID: 15313959
    [No Abstract]   [Full Text] [Related]  

  • 8. Influenza vaccine does not produce myopathy in patients taking statins.
    Chazan B; Weiss R; Tabenkin H; Mines M; Raz R
    J Fam Pract; 2002 Nov; 51(11):986, 988. PubMed ID: 12485562
    [No Abstract]   [Full Text] [Related]  

  • 9. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators.
    Whayne TF
    Angiology; 2011 Jul; 62(5):415-21. PubMed ID: 21421631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Muscle-sparing' statins: preclinical profiles and future clinical use.
    Pfefferkorn JA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):245-52. PubMed ID: 19333882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and benefits of statins in lupus erythematosus.
    Noël B
    Arch Intern Med; 2004 Jan; 164(1):107-8. PubMed ID: 14718334
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of cardiovascular disease with statins: cautionary notes.
    Goldstein MR; Mascitelli L; Pezzetta F
    QJM; 2009 Nov; 102(11):817-20. PubMed ID: 19620217
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins: The Good, the Bad, and the Unexpected.
    Mager DR
    Home Healthc Now; 2016; 34(7):388-93. PubMed ID: 27348033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myopathy associated with statin therapy.
    Hilton-Jones D
    Neuromuscul Disord; 2008 Jan; 18(1):97-8. PubMed ID: 17892936
    [No Abstract]   [Full Text] [Related]  

  • 16. My approach to patients intolerant to statins.
    Martin SS
    Trends Cardiovasc Med; 2015 Apr; 25(3):265-6. PubMed ID: 25802226
    [No Abstract]   [Full Text] [Related]  

  • 17. Needed: pragmatic clinical trials for statin-intolerant patients.
    Maningat P; Breslow JL
    N Engl J Med; 2011 Dec; 365(24):2250-1. PubMed ID: 22085320
    [No Abstract]   [Full Text] [Related]  

  • 18. Statin Intolerance From a Clinician's Perspective.
    Whayne TF
    Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins and risk of new-onset diabetes mellitus.
    Shah RV; Goldfine AB
    Circulation; 2012 Oct; 126(18):e282-4. PubMed ID: 23109518
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive lipid-lowering therapy: obvious benefits, possible risks.
    Zimlichman E; Szyper-Kravitz M; Katz U; Shoenfeld Y
    Isr Med Assoc J; 2006 Dec; 8(12):890-1. PubMed ID: 17214117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.